Floatz logo

Cyclobenzaprine

Adenomyosis

Christiana Care Health ServicesSmall moleculePhase 4 / ApprovedActive
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
43/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adenomyosis cohort.

Asset / SponsorPhaseRating
Indocyanine Green
Chen Chunlin
Early Phase 1CC
ORSYTHIA COMPONENT ETHINYL ESTRADIOL
University of Cagliari
N/AD
Levonorgestrel
University of Cagliari
N/AD

Same molecule, other indications

Cyclobenzaprine is also rated in:

morbid obesityDormant
B
Indicative ·
58 / 100
View asset →
Minimally Invasive Surgical ProceduresDormant
B
Indicative ·
58 / 100
View asset →
menstrual disorderDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →